Navigation Links
New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
Date:5/8/2012

:30 p.m.

(data presented at 2:45 p.m.)

PDT / 5:00 p.m. – 7:30 p.m.

(data presented at 5:45 p.m.) EDTEfficacy of the Tyrosine

Kinase Inhibitor BIBF 1120

in Patients with IPF:

Consistent Pattern of

Primary Endpoint Results

in Sensitivity Analyses of

the TOMORROW trial

L. Richeldi

Oral Presentation

 

Date: Monday, May 21

Time: 2:00 p.m – 4:30 p.m.

(data presented at 2:30 p.m.)

PDT / 5:00 p.m. – 7:30 p.m.

(data presented at 5:30 p.m.) EDTOlodaterolTitleLead Author Presentation details Comparison Of 24-Hour

FEV1 Profile For Once-

Daily Versus Twice-Daily

Treatment With

Olodaterol, A Novel Long-

Acting b2-Agonist, In

Patients With COPD

G. Joos

Thematic Poster # D60

 

Date: Monday, May 21

Time: 10:45 a.m – 12:30 p.m.

PDT / 1:45 p.m. – 3:30 p.m.

EDTLung FunctionTitleLead Author Presentation details Lung Function And

Exercise Impairment In

Patients With GOLD Stage

I And II COPD

D. E. O'Donnell

Thematic Poster  # G74

 

Date: Wednesday, May 23

Time: 8:15 a.m. – 4:30 p.m.

PDT / 11:15 a.m. – 7:30 p.m. EDT

Poster Discussion from

10:45 a.m. – 12:30 p.m. PDT /

1:45 p.m. – 3:30 p.m. EDTBoehringer Ingelheim: Leading respiratory forwardTreatment of respiratory diseases has been a major area of focus for Boehringer Ingelheim for more than 90 years and significant resources are dedicated to research in this field. In addition to new possible treatment options for COPD, Boehringer Ingelheim has also branched out into developing treatment options for other airway diseases, including asthma, lung cancer, idiopathic pulmonary fibrosis and other respiratory diseases.

About Boehringer Ingelheim
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Endo International plc (NASDAQ: ... announced today that it has commenced an underwritten public ... All ordinary shares in the offering are to be ... also grant to the underwriters of the Offering an ... the date of the final prospectus supplement, to purchase ...
(Date:6/2/2015)...  MGC Diagnostics Corporation (NASDAQ: MGCD ), ... results for the second quarter ended April 30, ... equipment, supplies and accessories revenues, compared to the ... During the quarter, competitive account conversions totaled 12 ... accounts, or $850,000 in revenue for the same ...
(Date:6/2/2015)... 2, 2015   PDI , a leader ... a series of corporate commitments designed to educate ... the threat of antimicrobial-resistant microorganisms as part of ... Disease Control and Prevention (CDC) and in support ... Antibiotic-Resistant Bacteria. Along with other key ...
Breaking Medicine Technology:Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2
... TORONTO, Nov. 8, 2010 Millennium Research Group ... intelligence, has released its latest surgical navigation systems ... geographies. These two reports cover the breakdown of ... used in neurosurgery, spine, ENT, orthopedic, and soft ...
... SALT LAKE CITY, Nov. 8, 2010 TechniScan, Inc. ... device company engaged in the development and commercialization of an ... its convertible debt. TechniScan entered into amendments with ... extend the maturity date of its entire portfolio of secured ...
Cached Medicine Technology:Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group 2TechniScan, Inc. Announces Restructuring of Convertible Debt 2
(Date:6/3/2015)... evigilo, a world leader in delivering ... new branding by launching a new and enhanced content-centric ... identity: the logo depicting a sun-like image with a ... – To Know. To Act. In time. The color ... A global, borderless approach to alerting and delivering safety ...
(Date:6/2/2015)... Prairie, WI (PRWEB) June 03, 2015 ... for regulated industries such as government, finance and healthcare. ... organization that wants reliable access control to enhance the ... card keyboard requires the secondary authentication of a Smart ... In addition to the smart-chipset card reader, the keyboard ...
(Date:6/2/2015)... MEDIA ADVISORY, June 2, 2015 ... Email: ewallace(at)mentalhealthamerica(dot)net , Breaking News: Congressman Tim Murphy ... at MHA Annual Conference Thursday , Who: Congressman ... address the Mental Health America Annual Conference attendees ... of the Helping Families in Mental Health Crisis ...
(Date:6/2/2015)... Los Angeles, CA (PRWEB) June 02, 2015 ... clinic have unveiled a plan to drive prolific change in ... progress, the TDC Team Dental Clinic offers a ... and an expert management structure for dental tourism. , Partnered ... dental care team is committed to advancing dentistry and has ...
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations and ... urgent care services in Los Angeles County. The ... California Board of Regents and the Exer Board of ... purchase a minority share of four existing Exer urgent ... Northridge and creates opportunity to grow and develop new, ...
Breaking Medicine News(10 mins):Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:UCLA Health Partners With Exer - More Than Urgent Care 2
... to earn the dubious distinction of becoming a country with ... better emergency facilities for heart patients could save lives, feel ... reports, India is likely to become the heart attack capital ... been spreading like an epidemic and have been affecting the ...
... Onyx Pharmaceuticals, Inc. today announced that Nexavar(R) (sorafenib) ... with hepatocellular carcinoma (HCC), or primary liver cancer ... presented at the 43rd annual meeting of the ... ,The international, Phase 3, placebo-controlled Sorafenib HCC Assessment ...
... two new investigational cancer therapies at the American Society ... a small molecule inhibitor of Poly-ADP Ribose Polymerase (PARP). ... Excision Repair which is a key pathway in the ... mechanism, in tandem with a defective DNA repair gene ...
... 4, 2007 An international team led by MUHC has ... is a common congenital blindness in infants and small children. ... Nature Genetics and is partly funded by the Foundation Fighting ... potential to fast-track a cure for this disease, says lead ...
... The winds of change and a yearning for variety are ... vodka and gin even as the old generation still ... ,As part of the global trend, the consumption of ... up in the subcontinent, thanks to the changing profile of ...
... to a University of Pittsburgh Medical Center (UPMC) study ... of Clinical Oncology (ASCO) in Chicago and published as ... for follicular lymphoma, a slow-growing type of non-Hodgkins lymphoma, ... ,Over 90 percent of study patients responded completely to ...
Cached Medicine News:Health News:Nexavar Significantly Extends Survival of Liver Cancer Patients 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 3Health News:Gene Responsible for Blindness in Infants and Children Identified 2Health News:Young Indians Say Cheers to White Spirits 2Health News:Young Indians Say Cheers to White Spirits 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2
QIAvac 6S provides all manifold components for processing QIAGEN 8-well strips....
Holder for QIAGEN 96-well plates, for use with QIAvac 96;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 384-well format...
Medicine Products: